ICH Expert Working Group, ICH Harmonised Guideline, M10, Bioanalytical Method Validation and Study Sample Analysis, International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. adopted on 24 May 2022.

Qu Q, Liu S, You Z, Steeno GS, Dyleski LA, Mu X, Wang Y, Baltrukonis D. A data driven strategy and case study for implementation of singlicate analysis in ligand binding assays used for PK quantitation. AAPS J. 2024;26:88.

Article  CAS  PubMed  Google Scholar 

Stanta JL, Craig H, Smith C, Chappell J. Comparing singlet and duplicate immunogenicity assay in human plasma for pembrolizumab using Gyrolab((R)). Bioanalysis. 2021;13(11):891–900.

Article  CAS  PubMed  Google Scholar 

Jiang Z, Kamerud J, You Z, Basak S, Seletskaia E, Steeno GS, Gorovits B. Feasibility of singlicate-based analysis in bridging ADA assay on Meso-Scale Discovery platform: comparison with duplicate analysis. Bioanalysis. 2021;13(14):1123–34.

Article  CAS  PubMed  Google Scholar 

U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), FDA Guidance for Industry, Immunogenicity Testing of Therapeutic Protein Products - Developing and Validating Assays for Anti-Drug Antibody Detection. Pharmaceutical Quality/CMC. 2019.

Committee for Medicinal Products for Human Use (CHMP), European Medicines Agency (EMA), Science Medicines Health, Guideline on Immunogenicity assessment of therapeutic proteins. 2017.

Smith HW, Deqin Sun AB. Detection of antibodies against therapeutic proteins in the presence of residual therapeutic protein using a solid-phase extraction with acid dissociation (SPEAD) sample treatment prior to ELISA. Regul Toxicol Pharmacol. 2007;49:230–7.

Article  CAS  PubMed  Google Scholar 

Olsson J, Rootzen H. Quantile estimation from repeated measurements. Am Stat Assoc. 1996;91(436):1560–5.

Article  Google Scholar 

Kubiak RJ, Zhang J, Ren P, Yang H, Roskos LK. Excessive outlier removal may result in cut points that are not suitable for immunogenicity assessments. J Immunol Methods. 2018;463:105–11.

Article  CAS  PubMed  Google Scholar 

Shankar G, Devanarayan V, Amaravadi L, Barrett YC, Bowsher R, Finco-Kentf D, Fiscella M, Gorovits B, Kirschner S, Moxness M, Parishk T, Quarmby V, Smith H, Smith W, Zuckerman LA, Koren E. Recommendations for the validation of immunoassays used for detection of host antibodies against biotechnology products. J Pharm Biomed Anal. 2008;48:1267–81.

Article  CAS  PubMed  Google Scholar 

Díaz-Francés E, Rubio FJ. On the existence of a normal approximation to the distribution of the ratio of two independent normal random variables. Stat Pap. 2012;54(2):309–23.

Article  Google Scholar 

Myler H, Pedras‑Vasconcelos J, Phillips K, Hottenstein CS, Chamberlain P, Devanaryan V, et al. Anti‑drug antibody validation testing and reporting Harmonization. AAPS J. 2022;24:4.

Kholmanskikh O, Wang YM, Hersey S, Wadhwa M, Block K, Bandukwala A, Szapacs M, Weiner R, Awwad K, Dessy F, Downing S, Xiulian D, Garofolo F, Harris S, Hou V, Jones J, Kar S, Kinhikar A, Li M, Mathews J, Meissen J, Sumner GO, Pan L, Sanderink G, Scully I, Stanta J, Tanaka Y, Vauleon S, Wagner L, Wang K, Zhu L, Eck S, Lin YD, Azadeh M, Decman V, Diebold S, Xiulian D, Goihberg P, Alcaide EG, Gonneau C, Hedrick MN, Hopkins G, Kar S, Loschko J, McCausland M, Mendez L, Sehra S, Stevens E, Sun YS, Tangri S, Trampont PC, Cludts I, Dysinger M, Kavita U, Sugimoto H, Chilewski S, Grimaldi C, Jiang Y, Kamerud J, Liu S, Owen C, Palackal N, Petit-frere C, Pine S, Abhari MR, Scheibner K, Williams L, Tao X, Zhang G. White Paper on Recent Issues in Bioanalysis: EU IVDR 2017/746 Implementation/Impact, IVD/CDx/CLIA Approved Assays, High Dimensional Cytometry, Multiplexing Technologies, LBA Tissue Analysis, Vaccine Study Endpoints, Cell-Based Assays for Biomarkers, Cell Therapy and Vaccines (PART 2 – Recommendations on Development & Validation of Biomarkers, IVD, CDx, Cell-Based, Flow Cytometry, Ligand-Binding and Enzyme Assays; Advanced Critical Reagents Strategies). Bioanalysis. 2024;16(8):179–220.

Article  PubMed  Google Scholar 

Pillutla RG, Gorovits B, Gleason C, Quiroz J, Christopher D, Braun M, Brockus C, Donaldson D, Haslberger T, He L, Qian M, Sydor J, Wickremsinhe E, Williams L. Recommendations for singlet-based approach in ligand binding assays: an IQ Consortium perspective. Bioanalysis. 2020;12(12):823–34.

Article  CAS  PubMed  Google Scholar 

Barfield M, Goodman J, Hood J, Timmerman P. European Bioanalysis Forum recommendation on singlicate analysis for ligand binding assays: time for a new mindset. Bioanalysis. 2020;12(5):273–84.

Article  CAS  PubMed  Google Scholar